[CADL] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
12-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 5.37%
YoY- -532.81%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 31 31 31 31 31 31 31 0.00%
PBT -4,149 -874 1,596 -16,162 -17,080 -4,478 -10,478 -46.16%
Tax -4,604 -8,112 12 14 15 191 4,504 -
NP 455 7,238 1,596 -16,162 -17,080 -4,478 -10,478 -
Tax Rate - - -0.75% - - - - -
Total Cost -424 -7,207 -1,565 16,193 17,111 4,509 10,509 -
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 1,467.74 23,348.39 5,148.39 -52,135.48 -55,096.77 -14,445.16 -33,800.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS 0.02 0.25 0.07 -0.69 -0.69 -0.24 -0.56 -
EPS Diluted 0.02 0.25 0.07 -0.69 -0.69 -0.24 -0.56 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.